GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →

healthcare

Latest articles

Image for Novo Nordisk to halve US list price of Wegovy from 2027
Finance

Novo Nordisk to halve US list price of Wegovy from 2027

Feb 24 (Reuters) - Danish drugmaker Novo Nordisk plans to slash U.S. list prices of its blockbuster...

24th February, 2026

Image for UK medical products maker Convatec lifts medium‑term revenue growth target
Finance

UK medical products maker Convatec lifts medium‑term revenue growth target

Feb 24 (Reuters) - Convatec lifted its medium-term organic revenue growth target on Tuesday, citing...

24th February, 2026

Image for Fresenius Medical Care's meek 2026 guidance sends shares falling
Finance

Fresenius Medical Care's meek 2026 guidance sends shares falling

Feb 24 (Reuters) - Fresenius Medical Care reported a sharp rise in fourth‑quarter operating income o...

24th February, 2026

Image for Analysis-Novo's stumbles burnish Lilly's widening lead in weight-loss drugs
Finance

Analysis-Novo's stumbles burnish Lilly's widening lead in weight-loss drugs

By Maggie Fick and Bhanvi Satija LONDON, Feb 24 (Reuters) - With U.S. arch rival Eli Lilly streaking...

24th February, 2026

Image for Italian region resists US pressure to curb use of Cuban doctors
Finance

Italian region resists US pressure to curb use of Cuban doctors

By Crispian Balmer ROME, Feb 23 (Reuters) - Cuban doctors are essential to keeping local hospitals r...

23rd February, 2026

Image for Bayer sues Johnson & Johnson over claim that prostate cancer drug cuts risk of death
Finance

Bayer sues Johnson & Johnson over claim that prostate cancer drug cuts risk of death

BERLIN, Feb 23 (Reuters) - German pharmaceutical company Bayer said on Monday that it had filed a la...

23rd February, 2026

Image for Instant View: Novo's CagriSema setback may shift investor focus to M&A strategy, analysts say
Finance

Instant View: Novo's CagriSema setback may shift investor focus to M&A strategy, analysts say

Feb 23 (Reuters) - Novo Nordisk's next-generation weight-loss drug CagriSema was less effective than...

23rd February, 2026

Image for Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped out
Finance

Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped out

Feb 23 (Reuters) - Novo Nordisk shares fell more than 15% on Monday, wiping away the last gains Wego...

23rd February, 2026

Image for Novo Nordisk's CagriSema trial deals blow in obesity drug battle with Eli Lilly
Finance

Novo Nordisk's CagriSema trial deals blow in obesity drug battle with Eli Lilly

COPENHAGEN, Feb 23 (Reuters) - Novo Nordisk said on Monday its experimental obesity drug CagriSema d...

23rd February, 2026

Image for India's LTIMindtree wins $100 million deal with European medtech firm
Finance

India's LTIMindtree wins $100 million deal with European medtech firm

Feb 23 (Reuters) - Indian IT services company LTIMindtree on Monday said it has won a $100 million d...

23rd February, 2026

Image for Sonova expects FY revenue at lower end of target range, CEO says in interview
Finance

Sonova expects FY revenue at lower end of target range, CEO says in interview

Feb 20 (Reuters) - Sonova's full year revenue will come at the lower end of its 2025/2026 forecast r...

20th February, 2026

Image for EU approves higher dose of Novo Nordisk's Wegovy
Finance

EU approves higher dose of Novo Nordisk's Wegovy

Feb 17 (Reuters) - The European Commission has approved a higher dose of Novo Nordisk's popular weig...

17th February, 2026